News from roche A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

11:30 ET Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for ...

May 18, 2021, 01:00 ET Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas® SARS-CoV-2 Test for use on the widely available, high-throughput cobas® 6800/8800...

Mar 09, 2021, 01:00 ET Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)

Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval of the VENTANA ALK (D5F3) CDx Assay as a companion...

Feb 11, 2021, 10:00 ET Roche receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the U.S. Food and Drug Administration (FDA) 510K clearance of stabilised urine samples to be used...

Oct 29, 2020, 12:45 ET Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of expanded claims for the cobas® EGFR Mutation...

Jul 30, 2020, 01:05 ET Roche launches cobas prime Pre-analytical System, a first-of-its-kind solution designed to automate all common manual steps in molecular diagnostics laboratories

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® prime Pre-analytical System to improve efficiency in molecular...

May 19, 2020, 16:26 ET Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its Elecsys® Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab...

Dec 12, 2019, 07:00 ET Roche and Fortelinea to co-market software solutions in US to improve workflow in histology research labs

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed a joint marketing agreement in the United States with Fortelinea Software...

Oct 14, 2019, 08:00 ET Roche Partners with iHeartMedia to Present 'iHeartCountry One Night For Our Military' Concert to Bring Further Awareness of The Impact Diabetes Has On The Nation's Veteran Population

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has again partnered with iHeartMedia, the number one audio company in the United States,...

May 28, 2019, 10:03 ET Roche launches first in vitro diagnostic IHC test to detect ROS1 protein in cancers

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, the first and...

May 23, 2019, 10:00 ET Roche receives FDA clearance to expand testing menu on cobas 6800/8800 Systems for sexually transmitted diseases

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on the...
Roche launches uPath enterprise software with improved speed, performance and usability for digital pathology

Jan 15, 2019, 10:02 ET Roche launches uPath enterprise software with improved speed, performance and usability for digital pathology

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its innovative uPath enterprise software[1] for digital pathology. Offering a new...

Dec 11, 2018, 10:05 ET Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it entered into a collaboration with Merck (known as MSD outside the United States and...

Nov 27, 2018, 07:00 ET Roche launches first IVD pan-TRK immunohistochemistry assay

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the VENTANA pan-TRK (EPR17341) Assay, the first automated in vitro diagnostic ...
Sepsis kills more Americans than opioid overdoses, breast cancer, and AIDS combined. Up to 80 percent of sepsis deaths are preventable. On World Sepsis Day, a new campaign seeks to drive sepsis awareness and save lives.

Sep 13, 2018, 14:36 ET Sepsis kills more Americans than opioid overdoses, breast cancer, and AIDS combined. Up to 80 percent of sepsis deaths are preventable. On World Sepsis Day, a new campaign seeks to drive sepsis awareness and save lives.

The Rory Staunton Foundation for Sepsis Prevention and Roche Diagnostics today announced the launch of a social media initiative aimed at driving...

Aug 23, 2018, 07:00 ET Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced approval from the U.S. Food and Drug Administration (FDA) for the cobas® EGFR Mutation Test v2 as...

Jul 30, 2018, 10:00 ET Roche's cobas HPV Test receives FDA approval for first-line cervical cancer screening using SurePath preservative fluid

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received U.S. Food and Drug Administration (FDA) approval for the cobas® HPV Test to...

Jul 13, 2018, 14:18 ET Roche PCT assay cleared for expanded use - Important tool in antibiotic resistance crisis

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the expanded...

Jun 25, 2018, 08:00 ET Roche erweitert Zugriff auf Diabetesmanagementlösung mySugr in den USA und Kanada

- Roche stärkt seine Position auf dem Gebiet der digitalen Gesundheit durch eine strategische Partnerschaft und Investitionen in Care Innovations. -...

Jun 25, 2018, 08:00 ET Roche amplía el acceso a la solución de gestión integrada de diabetes mySugr en EE. UU. y Canadá

- Roche refuerza su posición en salud digital con una asociación estratégica e inversión en Care Innovations. - La asociación permitirá que los...

Jun 25, 2018, 08:00 ET Roche élargit l'accès à la solution intégrée de gestion du diabète mySugr aux États-Unis et au Canada

- Roche consolide sa position dans le secteur de la santé numérique grâce à un partenariat stratégique et un investissement dans Care Innovations. -...

May 14, 2018, 01:00 ET FDA approves additional claim for Roche cobas Zika test

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today FDA approval of an additional claim for the cobas® Zika test for use on the cobas® 6800/8800...

May 01, 2018, 08:00 ET Roche Diabetes Care Rallies People Across the Country to Join the #BuckOffDiabetes Campaign

Roche Diabetes Care today announced the launch of #BuckOffDiabetes, a campaign that represents a bold, new attitude for taking on diabetes....

Apr 18, 2018, 07:17 ET Roche expands indication for cobas® EGFR Mutation Test v2 as a companion diagnostic with TAGRISSO®

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Premarket...

Apr 16, 2018, 01:00 ET Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for cobas® CT/NG for...